Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by pierre013on Sep 03, 2014 9:38pm
416 Views
Post# 22903968

RE:Pli has had only One NR since the CC

RE:Pli has had only One NR since the CCThe bulk of the shares are in good hands. PLI will be the next Valeant. Dr Laurin and his partners know more than anybody the intrinsic value embedded in the company. So they won't let it go for 10 or 15 dollars when they know that it will be over 50 the next 3 years after. The real value won't be known before 2020 or 2022. Long run to all. I will be very disappointed if PLI is bought under 50 dollars. Think about CGI in the 90's. 10,000 dollars became 3,5 millions. So we have to be patient, it will be the ride of a lifetime. GLTA
Bullboard Posts